Transient state change, but not permanent subtype change, after HER2-targeted therapy for HER2-positive breast cancer (Alliance)
- Citation:
- Cancer Res vol 79 (4 Suppl) Abstract nr P3-08-04
- Meeting Instance:
- SABCS 2018
- Year:
- 2019
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171
- Corr. Author:
- Authors:
- Maki Tanioka Joel S Parker Lynn N Henry Sara Tolaney Chau Dang Ian E Krop Lyndsay Harris David Hillman Mei Polley Donald A Berry Eric P Winer Lisa A Carey Charles M Perou
- Networks:
- LAPS-CT018, LAPS-MA036, LAPS-NC007, LAPS-NY016
- Study
- CALGB-40601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: